Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias

被引:0
作者
Kossak-Roth, Ute [1 ]
Saussele, Susanne [1 ]
Aul, Carlo [2 ]
Buechner, Thomas [3 ]
Doehner, Hartmut [4 ]
Dugas, Martin [5 ]
Ehninger, Gerhard [6 ]
Ganser, Arnold [7 ]
Giagounidis, Aristoteles [8 ]
Goekbuget, Nicola [9 ]
Griesshammer, Martin [10 ]
Hasford, Joerg [11 ]
Heuser, Michael [7 ]
Hiddemann, Wolfgang [12 ]
Hochhaus, Andreas [13 ]
Hoelzer, Dieter [9 ]
Niederwieser, Dietger [14 ]
Reiter, Andreas [1 ]
Roellig, Christoph [6 ]
Hehlmann, Ruediger [1 ]
机构
[1] Heidelberg Univ, Med Fak Mannheim, Pettenkoferstr 22, D-68169 Mannheim, Germany
[2] HELIOS St Johannes Klin, Klin Onkol & Hamatol, Duisburg, Germany
[3] Univ Klinikum, Med Klin A, Munster, Germany
[4] Univ Ulm Klinikum, Innere Med Klin 3, Ulm, Germany
[5] Univ Munster, Inst Med Informat, D-48149 Munster, Germany
[6] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany
[7] Med Hsch, Klin Hamatol Hamostaseol Onkol & Stammzelltranspl, Hannover, Germany
[8] Marien Hosp, Klin Onkol Hamatol & Palliativmed, Dusseldorf, Germany
[9] Onkologikum Frankfurt Museumsufer, Frankfurt, Germany
[10] Johannes Wesling Klinikum, Klin Hamatol Onkol & Palliativmed, Minden, Germany
[11] Univ Munich, Inst Med Informationsverarbeitung Biometrie & Epi, Munich, Germany
[12] Klinikum Univ, Med Klin & Poliklin 3, Campus Grosshadern, Munich, Germany
[13] Univ Klinikum, Klin Innere Med 2, Jena, Germany
[14] Univ Klinikum, Abt Hamatol & Internist Onkol, Leipzig, Germany
关键词
Competence network; Leukemia; Clinical studies; European cooperation; Management recommendations; CHRONIC MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HARMONIZING CURRENT METHODOLOGY; TYROSINE KINASE INHIBITORS; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; BCR-ABL TRANSCRIPTS; ADULTS RECOMMENDATIONS; MUTATION ANALYSIS; CLINICAL-TRIALS;
D O I
10.1007/s00103-016-2315-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The Competence Network "Acute and Chronic Leukemias" was founded in 1997 by the consolidation of the leading leukemia study groups in Germany. Key results are the development of new trials and cooperative studies, the setup of patient registries and biobanking facilities, as well as the improvement of study infrastructure. In 2003, the concept of the competence network contributed to the foundation of the European LeukemiaNet (ELN). Synergy with the ELN resulted in cooperation on a European and international level, standardization of diagnostics and treatment, and recommendations for each leukemia and interdisciplinary specialty. The ultimate goal of the network is the cure of leukemia through cooperative research.
引用
收藏
页码:444 / 453
页数:10
相关论文
共 46 条
  • [1] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
    Baccarani, Michele
    Deininger, Michael W.
    Rosti, Gianantonio
    Hochhaus, Andreas
    Soverini, Simona
    Apperley, Jane F.
    Cervantes, Francisco
    Clark, Richard E.
    Cortes, Jorge E.
    Guilhot, Francois
    Hjorth-Hansen, Henrik
    Hughes, Timothy P.
    Kantarjian, Hagop M.
    Kim, Dong-Wook
    Larson, Richard A.
    Lipton, Jeffrey H.
    Mahon, Francois-Xavier
    Martinelli, Giovanni
    Mayer, Jiri
    Mueller, Martin C.
    Niederwieser, Dietger
    Pane, Fabrizio
    Radich, Jerald P.
    Rousselot, Philippe
    Saglio, Giuseppe
    Saussele, Susanne
    Schiffer, Charles
    Silver, Richard
    Simonsson, Bengt
    Steegmann, Juan-Luis
    Goldman, John M.
    Hehlmann, Ruediger
    [J]. BLOOD, 2013, 122 (06) : 872 - 884
  • [2] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
    Baccarani, Michele
    Cortes, Jorge
    Pane, Fabrizio
    Niederwieser, Dietger
    Saglio, Giuseppe
    Apperley, Jane
    Cervantes, Francisco
    Deininger, Michael
    Gratwohl, Alois
    Guilhot, Francois
    Hochhaus, Andreas
    Horowitz, Mary
    Hughes, Timothy
    Kantarjian, Hagop
    Larson, Richard
    Radich, Jerald
    Simonsson, Bengt
    Silver, Richard T.
    Goldman, John
    Hehlmann, Rudiger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6041 - 6051
  • [3] Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
    Barbui, Tiziano
    Barosi, Giovanni
    Birgegard, Gunnar
    Cervantes, Francisco
    Finazzi, Guido
    Griesshammer, Martin
    Harrison, Claire
    Hasselbalch, Hans Carl
    Hehlmann, Rudiger
    Hoffman, Ronald
    Kiladjian, Jean-Jacques
    Kroeger, Nicolaus
    Mesa, Ruben
    McMullin, Mary F.
    Pardanani, Animesh
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    Reiter, Andreas
    Silver, Richard T.
    Verstovsek, Srdan
    Tefferi, Ayalew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) : 761 - 770
  • [4] A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process
    Barosi, Giovanni
    Birgegard, Gunnar
    Finazzi, Guido
    Griesshammer, Martin
    Harrison, Claire
    Hasselbalch, Hans
    Kiladijan, Jean-Jacques
    Lengfelder, Eva
    Mesa, Ruben
    Mc Mullin, Mary F.
    Passamonti, Francesco
    Reilly, John T.
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) : 961 - 963
  • [5] Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
    Barosi, Giovanni
    Birgegard, Gunnar
    Finazzi, Guido
    Griesshammer, Martin
    Harrison, Claire
    Hasselbalch, Hans Carl
    Kiladjian, Jean-Jacques
    Lengfelder, Eva
    McMullin, Mary Frances
    Passamonti, Francesco
    Reilly, John T.
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    [J]. BLOOD, 2009, 113 (20) : 4829 - 4833
  • [6] Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
    Bene, M. C.
    Nebe, T.
    Bettelheim, P.
    Buldini, B.
    Bumbea, H.
    Kern, W.
    Lacombe, F.
    Lemez, P.
    Marinov, I.
    Matutes, E.
    Maynadie, M.
    Oelschlagel, U.
    Orfao, A.
    Schabath, R.
    Solenthaler, M.
    Tschurtschenthaler, G.
    Vladareanu, A. M.
    Zini, G.
    Faure, G. C.
    Porwit, A.
    [J]. LEUKEMIA, 2011, 25 (04) : 567 - 574
  • [7] Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia
    Branford, S.
    Cross, N. C. P.
    Hochhaus, A.
    Radich, J.
    Saglio, G.
    Kaeda, J.
    Goldman, J.
    Hughes, T.
    [J]. LEUKEMIA, 2006, 20 (11) : 1925 - 1930
  • [8] Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm-Combined Prospective Analysis by the German AML Intergroup
    Buechner, Thomas
    Schlenk, Richard F.
    Schaich, Markus
    Doehner, Konstanze
    Krahl, Rainer
    Krauter, Juergen
    Heil, Gerhard
    Krug, Utz
    Sauerland, Maria Cristina
    Heinecke, Achim
    Spaeth, Daniela
    Kramer, Michael
    Scholl, Sebastian
    Berdel, Wolfgang E.
    Hiddemann, Wolfgang
    Hoelzer, Dieter
    Hehlmann, Ruediger
    Hasford, Joerg
    Hoffmann, Verena S.
    Doehner, Hartmut
    Ehninger, Gerhard
    Ganser, Arnold
    Niederwieser, Dietger W.
    Pfirrmann, Markus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (29) : 3604 - 3610
  • [9] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
    Cilloni, Daniela
    Renneville, Aline
    Hermitte, Fabienne
    Hills, Robert K.
    Daly, Sarah
    Jovanovic, Jelena V.
    Gottardi, Enrico
    Fava, Milena
    Schnittger, Susanne
    Weiss, Tamara
    Izzo, Barbara
    Nomdedeu, Josep
    van der Heijden, Adrian
    van der Reijden, Bert A.
    Jansen, Joop H.
    van der Velden, Vincent H. J.
    Ommen, Hans
    Preudhomme, Claude
    Saglio, Giuseppe
    Grimwade, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5195 - 5201
  • [10] The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
    Cornelissen, Jan J.
    Gratwohl, Alois
    Schlenk, Richard F.
    Sierra, Jorge
    Bornhaeuser, Martin
    Juliusson, Gunnar
    Racil, Zdenek
    Rowe, Jacob M.
    Russell, Nigel
    Mohty, Mohamad
    Lowenberg, Bob
    Socie, Gerard
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) : 579 - 590